1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and chrysin

1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with chrysin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al-Asri, J; Fazekas, E; Görick, C; Gyémánt, G; Lehoczki, G; Melzig, MF; Mortier, J; Perdih, A; Wolber, G	1
Chen, WJ; Chen, YJ; Huang, C; Huang, HC; Lin, CL; Wei, YX	1

Other Studies

2 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and chrysin

Article	Year
From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors. Bioorganic & medicinal chemistry, 2015, Oct-15, Volume: 23, Issue:20 Topics: alpha-Amylases; Carbohydrates; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship	2015
Combined treatment with chrysin and 1,2,3,4,6-penta-O-galloyl-β-D-glucose synergistically inhibits LRP6 and Skp2 activation in triple-negative breast cancer and xenografts. Molecular carcinogenesis, 2015, Volume: 54, Issue:12 Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Synergism; Female; Flavonoids; Heterografts; Humans; Hydrolyzable Tannins; Low Density Lipoprotein Receptor-Related Protein-6; Mice, Inbred BALB C; Mice, Nude; S-Phase Kinase-Associated Proteins; Triple Negative Breast Neoplasms	2015

Article

Year

From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.

Bioorganic & medicinal chemistry, 2015, Oct-15, Volume: 23, Issue:20

Topics: alpha-Amylases; Carbohydrates; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship

2015

Combined treatment with chrysin and 1,2,3,4,6-penta-O-galloyl-β-D-glucose synergistically inhibits LRP6 and Skp2 activation in triple-negative breast cancer and xenografts.

Molecular carcinogenesis, 2015, Volume: 54, Issue:12

Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Synergism; Female; Flavonoids; Heterografts; Humans; Hydrolyzable Tannins; Low Density Lipoprotein Receptor-Related Protein-6; Mice, Inbred BALB C; Mice, Nude; S-Phase Kinase-Associated Proteins; Triple Negative Breast Neoplasms

2015